Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery

详细信息    查看全文

• 作者：Karim D. Mahmoud ; MD ; PhD^a ; ^b ; Saurabh Sanon ; MD^a ; Elizabeth B. Habermann ; PhD ; MPH^c ; Ryan J. Lennon ; MS^d ; Kristine M. Thomsen ; BA^c ; Douglas L. Wood ; MD^e ; ^f ; Felix Zijlstra ; MD ; PhD^b ; Robert L. Frye ; MD^a ; David R. Holmes Jr. ; MD^a ; ^{holmes.david@mayo.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：coronary artery disease ; percutaneous coronary intervention ; perioperative care ; risk factors ; stents ; surgery
• 刊名：Journal of the American College of Cardiology
• 出版年：2016
• 出版时间：8 March 2016
• 年：2016
• 卷：67
• 期：9
• 页码：1038-1049
• 全文大小：983 K

文摘

Previous studies have observed high rates of perioperative cardiovascular events in patients with coronary stents undergoing noncardiac surgery (NCS). It is uncertain whether this finding reflects an independent association.

Objectives

The goal of this study was to assess the independent relationship between prior coronary stent implantation and the occurrence of perioperative major adverse cardiac and cerebrovascular events (MACCE) and bleeding and its relation with time from stenting to NCS.

Methods

A total of 24,313 NCS cases at the Mayo Clinic (Rochester, Minnesota) from 2006 through 2011 were included in the study; 1,120 (4.6%) cases involved patients with coronary stents. MACCE was defined as death, myocardial infarction, cardiac arrest, or stroke. Age-adjusted odds ratios (aORs) were calculated after propensity adjustment for Revised Cardiac Risk Index factors and other conventional risk factors.

Results

The 30-day MACCE rates were 3.7% and 1.5% in stented and unstented patients, respectively (p < 0.001). The risk of MACCE was largely related to the time from stent implantation to NCS, indicating substantially elevated risk in the first year after stenting (aOR: 2.59; 95% confidence interval [CI]: 1.36 to 4.94) but not thereafter (aOR: 0.89; 95% CI: 0.59 to 1.36). Bleeding displayed a similar pattern, indicating elevated risk in the first year after stenting (aOR: 2.23; 95% CI: 1.55 to 3.21) but not thereafter (aOR: 1.07; 95% CI: 0.89 to 1.28). Subgroup analysis in patients with known stent type found that the increased risk of both MACCE and bleeding >1 month after stent implantation was not limited to only those with drug-eluting stents.

Conclusions

This study found that prior coronary stent implantation is an independent risk factor for MACCE and bleeding when time from stenting to NCS is <1 year, both in patients with bare-metal and drug-eluting stents.